H2Treatment Attenuated Pain Behavior and Cytokine Release Through the HO-1/CO Pathway in a Rat Model of Neuropathic Pain

Inflammation

Volumn 38, Issue 5, 2015, Pages 1835-1846

  Chen, Yajun ^a   Chen, Hongguang ^a   Xie, Keliang ^a   Liu, Lingling ^a   Li, Yuan ^a   Yu, Yonghao ^a   Wang, Guolin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CO; cytokines; H2; HO 1; inflammation; neuropathic pain

Indexed keywords

CARBON MONOXIDE; CYTOKINE; HEME OXYGENASE 1; HEMIN; HIGH MOBILITY GROUP B1 PROTEIN; HYDROGEN; INTERLEUKIN 1BETA; MESSENGER RNA; PROTOPORPHYRIN; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; COLD SENSITIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; DORSAL ROOT; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NEURALGIA; PHYSIOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; CARBON MONOXIDE; CYTOKINES; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HYDROGEN; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84941183391     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0161-x     Document Type: Article

References (49)

1. Da, S.K., A.F. Paszcuk, G.F. Passos, E.S. Silva, A.F. Bento, and F.C. Meotti. 2011. Activation of cannabinoid receptors by the pentacyclic triterpene alpha, beta-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain 152: 1872–87.
2. Lavertu, G., S.L. Cote, and Y. de Koninck. 2014. Enhancing K-Cl co-transport restores normal spinothalamic sensory coding in a neuropathic pain model. Brain 137: 724–38.
3. Bijjem, K.R., S.S. Padi, and S.P. Lal. 2013. Pharmacological activation of heme oxygenase (HO)-1/carbon monoxide pathway prevents the development of peripheral neuropathic pain in Wistar rats. Naunyn-Schmiedeberg’s Archives of Pharmacology 386: 79–90.
4. Nadeau, S., M. Filali, J. Zhang, B.J. Kerr, S. Rivest, D. Soulet, Y. Iwakura, J.P. de Rivero Vaccari, R.W. Keane, and S. Lacroix. 2011. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1beta and TNF: implications for neuropathic pain. Journal of Neuroscience 31: 12533–42.
5. Watkins, L.R., M.R. Hutchinson, E.D. Milligan, and S.F. Maier. 2007. “Listening” and “talking” to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Research Reviews 56: 148–69.
6. Verri, W.J., T.M. Cunha, C.A. Parada, S. Poole, F.Q. Cunha, and S.H. Ferreira. 2006. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacology and Therapeutics 112: 116–38.
7. Scholz, J., and C.J. Woolf. 2007. The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience 10: 1361–8.
8. Vale, M.L., J.B. Marques, C.A. Moreira, F.A. Rocha, S.H. Ferreira, S. Poole, F.Q. Cunha, and R.A. Ribeiro. 2003. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. Journal of Pharmacology and Experimental Therapeutics 304: 102–8.
9. Fan, W., F. Huang, Z. Wu, X. Zhu, D. Li, and H. He. 2011. Carbon monoxide: a gas that modulates nociception. Journal of Neuroscience Research 89: 802–7.
10. Rosa, A.O., J. Egea, S. Lorrio, A.I. Rojo, A. Cuadrado, and M.G. Lopez. 2008. Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice. Pain 137: 332–9.
11. Egea, J., A.O. Rosa, S. Lorrio, B.L. Del, A. Cuadrado, and M.G. Lopez. 2009. Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test. Pain 146: 75–83.
12. Maicas, N., M.L. Ferrándiz, I. Devesa, R. Motterlini, M.I. Koenders, W.B. van den Berg, and M.J. Alcaraz. 2010. The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model. European Journal of Pharmacology 634: 184–91.
13. Chen, H.G., K.L. Xie, H.Z. Han, W.N. Wang, D.Q. Liu, G.L. Wang, and Y.H. Yu. 2013. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages. International Journal of Surgery 11: 1060–6.
14. Ohsawa, I., M. Ishikawa, K. Takahashi, M. Watanabe, K. Nishimaki, K. Yamagata, K. Katsura, Y. Katayama, S. Asoh, and S. Ohta. 2007. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine 13: 688–94.
15. Xie, K., W. Fu, W. Xing, A. Li, H. Chen, H. Han, Y. Yu, and G. Wang. 2012. Combination therapy with molecular hydrogen and hyperoxia in a murine model of polymicrobial sepsis. Shock 38: 656–63.
16. Xie, K., Y. Yu, Y. Pei, L. Hou, S. Chen, L. Xiong, and G. Wang. 2010. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock 34: 90–7.
17. Xie, K., Y. Yu, Z. Zhang, W. Liu, Y. Pei, L. Xiong, L. Hou, and G. Wang. 2010. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock 34: 495–501.
18. Chen, Q., P. Chen, S. Zhou, X. Yan, J. Zhang, X. Sun, H. Yuan, and W. Yu. 2013. Hydrogen-rich saline attenuated neuropathic pain by reducing oxidative stress. Canadian Journal of Neurological Sciences 40: 857–63.
19. Bao, Y.H., Q.H. Zhou, R. Chen, H. Xu, L.L. Zeng, X. Zhang, W. Jiang, and D.P. Du. 2014. Gabapentin enhances the morphine anti-nociceptive effect in neuropathic pain via the interleukin-10-heme oxygenase-1 signalling pathway in rats. Journal of Molecular Neuroscience 54: 137–46.
20. Bennett, G.J., and Y.K. Xie. 1998. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87–107.
21. Hayashida, K., M. Sano, I. Ohsawa, K. Shinmura, K. Tamaki, K. Kimura, J. Endo, T. Katayama, A. Kawamura, S. Kohsaka, S. Makino, S. Ohta, S. Ogawa, and K. Fukuda. 2008. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochemical and Biophysical Research Communications 373: 30–5.
22. Chaplan, S.R., F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh. 1994. Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 53: 55–63.
23. Bianchi, M., P. Sacerdote, P. Ricciardi-Castagnoli, P. Mantegazza, and A.E. Panerai. 1992. Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity. Neuroscience Letters 148: 76–80.
24. Andersson, U., and K.J. Tracey. 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annual Review of Immunology 29: 139–62.
25. Hervera, A., S. Leanez, R. Motterlini, and O. Pol. 2013. Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of micro-opioid receptors during neuropathic pain. Anesthesiology 118: 1180–97.
26. Su, L., C. Wang, Y.H. Yu, Y.Y. Ren, K.L. Xie, and G.L. Wang. 2011. Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain. BMC Neuroscience 12: 120.
27. Kawaguchi, M., Y. Satoh, Y. Otsubo, and T. Kazama. 2014. Molecular hydrogen attenuates neuropathic pain in mice. PLoS One 9: e100352.
28. Khalil, Z., T. Liu, and R.D. Helme. 1999. Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic constriction injury. Pain 79: 31–7.
29. Zhang, F., X. Feng, R. Dong, H. Wang, J. Liu, W. Li, J. Xu, and B. Yu. 2011. Effects of clonidine on bilateral pain behaviors and inflammatory response in rats under the state of neuropathic pain. Neuroscience Letters 505: 254–9.
30. DeLeo, J.A., and R.P. Yezierski. 2001. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90: 1–6.
31. Grace, P.M., P.E. Rolan, and M.R. Hutchinson. 2011. Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Brain, Behavior, and Immunity 25: 1322–32.
32. Sacerdote, P., S. Franchi, S. Moretti, M. Castelli, P. Procacci, V. Magnaghi, and A.E. Panerai. 2013. Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. Journal of Neuroimmune Pharmacology 8: 202–11.
33. Sacerdote, P., S. Franchi, A.E. Trovato, A.E. Valsecchi, A.E. Panerai, and M. Colleoni. 2008. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neuroscience Letters 436: 210–3.
34. Muthuraman, A., and N. Singh. 2012. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. Journal of Ethnopharmacology 142: 723–31.
35. Jaggi, A.S., and N. Singh. 2010. Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats. European Journal of Pharmacology 648: 102–9.
36. Kukkar, A., N. Singh, and A.S. Jaggi. 2013. Neuropathic pain-attenuating potential of aliskiren in chronic constriction injury model in rats. Journal of the Renin-Angiotensin-Aldosterone System 14: 116–23.
37. Kawasaki, Y., Z.Z. Xu, X. Wang, J.Y. Park, Z.Y. Zhuang, P.H. Tan, Y.J. Gao, K. Roy, G. Corfas, E.H. Lo, and R.R. Ji. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nature Medicine 14: 331–6.
38. Uceyler, N., A. Tscharke, and C. Sommer. 2007. Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain, Behavior, and Immunity 21: 553–60.
39. Perrin, F.E., S. Lacroix, M. Aviles-Trigueros, and S. David. 2005. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 128: 854–66.
40. Ruohonen, S., M. Khademi, M. Jagodic, H.S. Taskinen, T. Olsson, and M. Roytta. 2005. Cytokine responses during chronic denervation. Journal of Neuroinflammation 2: 26.
41. Kawasaki, Y., L. Zhang, J.K. Cheng, and R.R. Ji. 2008. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. Journal of Neuroscience 28: 5189–94.
42. Zhang, R.X., A. Li, B. Liu, L. Wang, K. Ren, H. Zhang, B.M. Berman, and L. Lao. 2008. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 135: 232–239.
43. Milligan, E.D., C. Twining, M. Chacur, J. Biedenkapp, K. O’Connor, S. Poole, K. Tracey, D. Martin, S.F. Maier, and L.R. Watkins. 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. Journal of Neuroscience 23: 1026–40.
44. Shibasaki, M., M. Sasaki, M. Miura, K. Mizukoshi, H. Ueno, S. Hashimoto, Y. Tanaka, and F. Amaya. 2010. Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 149: 514–21.
45. Tong, W., W. Wang, J. Huang, N. Ren, S.X. Wu, and Y.Q. Li. 2010. Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochemical and Biophysical Research Communications 395: 572–6.
46. Lawrence, S., L. Willmott, E. Milligan, S. Winch, B. White, and M. Parker. 2012. Autonomy versus futility? Barriers to good clinical practice in end-of-life care: a Queensland case. Medical Journal of Australia 196: 404–5.
47. Steiner, A.A., L.G. Branco, F.Q. Cunha, and S.H. Ferreira. 2001. Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. British Journal of Pharmacology 132: 1673–82.
48. Motterlini, R., J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, and C.J. Green. 2002. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circulation Research 90: E17–E24.
49. Guillen, M.I., J. Megias, V. Clerigues, F. Gomar, and M.J. Alcaraz. 2008. The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes. Rheumatology (Oxford) 47: 1323–8.